Missing/wrong data?
Log in to edit
MONARCH 1, A Phase II Study of Abemaciclib, a CDK4 and CDK6 Inhibitor, as a Single Agent, in Patients with Refractory HR+/HER2- Metastatic Breast Cancer
scientific article published on 22 May 2017
Author/s
author: Javier Cortes, Hope Rugo, Denise A Yardley, Joyce O'Shaughnessy, Sara M Tolaney, José Baselga
Work details
Publication date
May 22, 2017
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.